+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05701917

Comparison of ClotTriever Thrombectomy System Versus Anticoagulation Therapy Alone for Symptomatic Unilateral Iliofemoral Deep Vein Thrombosis

Led by Inari Medical · Updated on 2026-11-03

300

Participants Needed

64

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two treatment strategies for patients with symptomatic unilateral iliofemoral deep vein thrombosis DVT. This prospective, multicenter, randomized controlled trial compares an interventional approach using the ClotTriever System to achieve and maintain vessel openness against conservative medical management relying on anticoagulation therapy alone. The study aims to collect detailed data on patient demographics, comorbidities, diagnosis, treatment, and clinical outcomes over a six-month follow-up period. Participants will be randomly assigned to one of two groups the ClotTriever Intervention Arm, where the device is used to remove blood clots mechanically, or the Conservative Medical Management Arm, where patients receive anticoagulation medications such as Heparin Sodium, Coumadin, Rivaroxaban, or Apixaban. The trial includes approximately 300 subjects and evaluates treatments delivered according to the assigned strategy for symptomatic unilateral iliofemoral DVT. During the study, participants will be monitored through regular assessments including clinical evaluations and measurement of outcomes such as a composite clinical endpoint assessed at 10 days and at 180 days post-treatment. Researchers will also assess the severity of post-thrombotic syndrome PTS at 180 days. Data collection includes demographics and clinical details relevant to DVT diagnosis and management. Safety and efficacy will be monitored through follow-up visits over a six-month period to understand treatment impact and patient outcomes.

CONDITIONS

Brief Title

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Research Team

M

Mark Sung

S

Sara Willis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here